Skadden is advising Bowhead Specialty Holdings Inc., while Latham & Watkins is advising the underwriters in the transaction. Bowhead Specialty Holdings Inc. has priced its upsized...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
K&L Gates advised Rocket, and Latham advised underwriters. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented AlloVir, and Latham & Watkins represented the underwriters in the offering. AlloVir, Inc. (Nasdaq: ALVR) announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin represented RadNet, and Latham & Watkins represented the underwriters. RadNet, Inc. (NASDAQ: RDNT) has announced the closing of its underwritten public offering of 8,711,250 shares...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Skyward Specialty, and Latham advised the underwriters. Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) closed on June 12, 2023 its underwritten offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises subsidiaries of UGI Corporation on US$500 million senior notes offering and related tender offer. UGI Corporation, a distributor and marketer of energy...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of...
You must be a Standard 1 Year member to access this content.
Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
You must be a Standard 1 Year member to access this content.
DLA Piper represented Liquidia, while Latham & Watkins represented the underwriters in the offering. Liquidia Corporation, a biopharmaceutical company focused on the development and commercialization of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering. AMC Entertainment Holdings, Inc., the largest movie exhibition company in the United States, the largest in...
You must be a Standard 1 Year member to access this content.
